Literature DB >> 11709360

Newer macrolides as empiric treatment for acute Q fever infection.

A Gikas1, D P Kofteridis, A Manios, J Pediaditis, Y Tselentis.   

Abstract

The effectiveness of newer macrolides in acute Q fever for 113 patients was recorded. The mean times to defervescence were 2.9 days for doxycycline and 3.3, 3.9, 3.9, and 6.4 days for clarithromycin, roxithromycin, erythromycin, and beta-lactams, respectively (P < 0.01 for macrolides versus beta-lactams). We conclude that macrolides may be an adequate empirical antibiotic therapy for acute Q fever.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11709360      PMCID： PMC90889          DOI： 10.1128/AAC.45.12.3644-3646.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections.

Authors:  D Raoult; H Tissot-Dupont; C Foucault; J Gouvernet; P E Fournier; E Bernit; A Stein; M Nesri; J R Harle; P J Weiller
Journal:  Medicine (Baltimore)       Date:  2000-03       Impact factor: 1.889

2.  Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells.

Authors:  D Raoult; M Drancourt; G Vestris
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Q fever: a study of 111 consecutive cases.

Authors:  D W Spelman
Journal:  Med J Aust       Date:  1982-06-26       Impact factor: 7.738

4.  In vivo response of acute Q fever to erythromycin.

Authors:  M E Ellis; E M Dunbar
Journal:  Thorax       Date:  1982-11       Impact factor: 9.139

5.  Q fever treated with erythromycin.

Authors:  L J D'Angelo; R Hetherington
Journal:  Br Med J       Date:  1979-08-04

6.  Q fever in Plymouth, 1972-88. A review with particular reference to neurological manifestations.

Authors:  S Reilly; J L Northwood; E O Caul
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

7.  [Clinical aspects observed during an epidemic of 415 cases of Q fever].

Authors:  G Dupuis; O Péter; D Pedroni; J Petite
Journal:  Schweiz Med Wochenschr       Date:  1985-06-15

8.  Q fever in the Basque Country: 1981-1984.

Authors:  M Montejo Baranda; J Corral Carranceja; C Aguirre Errasti
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

9.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

10.  In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.

Authors:  A Gikas; I Spyridaki; A Psaroulaki; D Kofterithis; Y Tselentis
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191
View more
  13 in total

Review 1.  Q fever in adults: review of 66 clinical cases.

Authors:  M Sampere; B Font; J Font; I Sanfeliu; F Segura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-02-18       Impact factor: 3.267

2.  Use of macrolides for Q fever.

Authors:  Didier Raoult
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever.

Authors:  Peter M Schneeberger; Mirjam H A Hermans; Erik J van Hannen; Jeroen J A Schellekens; Alexander C A P Leenders; Peter C Wever
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

4.  Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy.

Authors:  Matthew P Rubach; Venance P Maro; John A Bartlett; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

Review 5.  Antimicrobial therapies for Q fever.

Authors:  Gilbert J Kersh
Journal:  Expert Rev Anti Infect Ther       Date:  2013-09-27       Impact factor: 5.091

6.  Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.

Authors:  Robert E Brennan; James E Samuel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  A case of acute q Fever with severe acute cholestatic hepatitis.

Authors:  Hyun Cheul Choi; Sang Hyub Lee; Junghee Kim; Sung Han Kim; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Haeryoung Kim
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

8.  High Coxiella burnetii DNA load in serum during acute Q fever is associated with progression to a serologic profile indicative of chronic Q fever.

Authors:  C C H Wielders; P C A Wijnbergen; N H M Renders; J J A Schellekens; P M Schneeberger; P C Wever; M H A Hermans
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

9.  Azithromycin for acute Q fever in pregnancy.

Authors:  Dasa Cerar; Primoz Karner; Tatjana Avsic-Zupanc; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Molecular method for the characterization of Coxiella burnetii from clinical and environmental samples: variability of genotypes in Spain.

Authors:  Isabel Jado; Cristina Carranza-Rodríguez; Jesús Félix Barandika; Álvaro Toledo; Cristina García-Amil; Beatriz Serrano; Margarita Bolaños; Horacio Gil; Raquel Escudero; Ana L García-Pérez; A Sonia Olmeda; Ianire Astobiza; Bruno Lobo; Manuela Rodríguez-Vargas; José Luis Pérez-Arellano; Fernando López-Gatius; Francisco Pascual-Velasco; Gustavo Cilla; Noé F Rodríguez; Pedro Anda
Journal:  BMC Microbiol       Date:  2012-06-01       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.